Angina symptoms at baseline should not be used alone to guide percutaneous coronary intervention (PCI) decisions in patients with severe aortic stenosis and clinically significant coronary artery disease undergoing transcatheter aortic valve implantation (TAVI), researchers suggest in a new analysis of the NOTION-3 trial.